Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Inks DNA Testing Contract with New Zealand

NEW YORK, April 13 (GenomeWeb News) - Orchid BioSciences Europe will provide DNA testing services to the New Zealand immigration authorities, parent company Orchid BioSciences said today.

 

Under the three-year contract, which is potentially renewable for two years, Orchid will test DNA samples from applicants seeking residency in New Zealand to determine their biological relationships to family members.

 

Under New Zealand law, certain relatives of citizens and permanent residents are allowed to immigrate. DNA testing will be applied to applicants from countries with record systems that do not satisfy the requirements of the New Zealand Immigration Service.

 

Orchid BioSciences Europe, based in Abingdon, UK, already provides immigration DNA testing for the UK and Norway. The company resulted from Orchid's acquisition of Cellmark Diagnostics in 2001.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.